Cerebrovascular events in adult Takayasu arteritis Circulatory System
Conditions
Interventions
The researchers retrospectively collected 1071 TA subjects and enrolled the patients with CVEs between January 2000 and December 2024. The incidence, clinical features, management strategy and prognos
Sponsors
Affiliated Chuiyangliu Hospital of Tsinghua University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adult patients with TA fulfilling the criteria of the American College of Rheumatology
Exclusion criteria
Exclusion criteria: Clinical remission criteria: absence of new symptoms and normalized erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause mortality at 1, 6, 12 months and every year, collected from medical records | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence of stroke/TIA at 1, 6, 12 months and every year, collected from medical records | — |
Countries
China
Contacts
Public ContactJunting Huo
Outcome results
None listed